Corporate / M&A

IP / IT

Capital Markets

Employment and Executive Compensation

Bioversys

Homburger News

20250129_Bioversys

On January 29, 2025, BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland, announced the launch of its Initial Public Offering (IPO) on SIX Swiss Exchange, the publication of the offer price and the start of the bookbuilding process. The IPO comprises a primary offering targeting gross proceeds of CHF 80 m (including an over-allotment option targeting gross proceeds of CHF 5 m). The implied market capitalization of the company, assuming all offered shares are sold in the IPO and the over-allotment option is exercised in full, is approximately CHF 212.9 m. The first day of trading is expected to be February 7, 2025.
BioVersys focuses on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The Company&#8217;s most advanced R&amp;D programs address nosocomial pneumonia and blood stream infections caused by Acinetobacter baumannii (BV100, phase 3-ready) and tuberculosis (alpibectir, phase 2a). In addition to its domicile in the biotech hub in Basel, Switzerland, BioVersys has operations in in Lille, France, Delaware, United States and Guangzhou, China.
Citigroup Global Markets Limited, UBS AG and Stifel Europe AG are acting as Joint Global Coordinators and Joint Bookrunners on the IPO, Mirabaud &amp; Cie SA and Octavian AG as Selling Agents.
Homburger is advising BioVersys on all aspects of the IPO as lead counsel. The Homburger team is co-led by Dieter Gericke and Lorenzo Togni and includes Thierry Burckhardt, Magda Aref, Simone Schmid, Raphael Linder, Harun Cetin and Leander Etter (all Corporate / M&amp;A and Capital Markets). Luca Dal Molin and Kristina Martinovic (both IP / IT) are providing intellectual property advice, Jeremy Reichlin (Employment and Executive Compensation) is providing employment and executive compensation advice, and Reto Heuberger and Philippe Weber (both Tax) are providing tax advice.

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Financing and Investment Products

Real Estate

Regulatory

YODA plc_web_640x140

Share-Image Teamplate Deals-and-Cases

On December 27, 2024, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its major investment into ULTIMA CAPITAL SA (Ultima), a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA).
As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Papacamp Investments Limited (Papacamp) at a contribution value of approximately CHF 484.6 m in return for 8,076,667 newly-issued shares of Ultima. Papacamp indirectly owns real estate properties and real estate developments in Greece within the luxury hospitality sector. As a result of the transaction, Yoda has become Ultima&#8217;s largest shareholder, with a shareholding interest in Ultima of approximately 53.8%. In addition, Yoda has granted Ultima a loan in the amount of CHF 71 m.
The Homburger team advising Yoda on all aspects of the transaction was led by Stefan Blunschi and included Micha Fankhauser, Oliver Kneubühl, Jonas Stähli and Leander Etter (all Corporate / M&amp;A), Lorenzo Togni and Kaiyan Yeo (both Capital Markets), Claudia Suter, Philippe Weber and Philippe Gobet (all Tax), Stefan Bindschedler and Nathalie Scherrer (both Financing and Investment Products), Stefan Gäumann and Olivier Bühlmann (both Real Estate), and Richard Stäuber and David Thomann (both Regulatory).

Leander
Etter

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Homburger advised Yoda PLC on its investment into ULTIMA CAPITAL SA

Join the Team

Leander Etter

Career

Languages

Bar Registration

Teams

LeanderEtter

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Homburger advised Yoda PLC on its investment into ULTIMA CAPITAL SA

Join the Team

Leander Etter

Career

Languages

Bar Registration

Teams

Leander
Etter